End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
5-day change
1st Jan Change
10,870
KRW
+0.74%
+2.26%
-1.27%
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on October 13, 2022, has closed with 100,000 shares, representing 1.03% for KRW 1,121.97 million.
The company closed its plan on January 3, 2022.
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-14
CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-20
CI
Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on October 13, 2022.
23-01-05
CI
Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on October 13, 2022.
23-01-05
CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on October 13, 2022, has closed with 100,000 shares, representing 1.03% for KRW 1,121.97 million.
23-01-02
CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-27
CI
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.
22-10-12
CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.
22-10-12
CI
Choong Ang Vaccine Laboratory Co., Ltd.(KOSDAQ:A072020) dropped from S&P Global BMI Index
22-09-19
CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-26
CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on October 8, 2021, has expired.
22-01-06
CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-26
CI
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.
21-10-08
CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan Shortened to January 7, 2022.
21-10-07
CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.
21-10-07
CI
Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on March 13, 2020.
20-03-19
CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on March 13, 2020 has closed with 100,000 shares, representing 1% for KRW 1,385.28 million.
20-03-17
CI
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.
20-03-13
CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.
20-03-12
CI
Choong Ang Vaccine Laboratory Co., Ltd.(KOSDAQ:A072020) added to S&P Global BMI Index
18-09-24
CI
Choong Ang Vaccine Laboratory Co., Ltd.(KOSDAQ:A072020) dropped from S&P Global BMI Index
17-09-18
CI
Choong Ang Vaccine Laboratory Co., Ltd.(KOSDAQ:A072020) added to S&P Global BMI Index
16-09-19
CI
Korea Securities Finance Corporation, Investment Arm acquired 5.09% stake in Choong Ang Vaccine Laboratory.
14-04-11
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Choong Ang Vaccine Laboratory Co., Ltd. is a Korea-based company mainly engaged in the manufacturing and marketing of veterinary vaccines. The Company provides veterinary vaccines for fowl, dogs, pigs, cattle, rabbits, cats, fishes and others under the brand name SuiShot, PoulShot, Canishot, BoviShot, FeliShot, RabbiShot and AquaShot. The Company also provides diagnosis services, and distributes other veterinary drugs, such as antibiotics, anthelmintics, disinfectants and feed additives. The Company distributes its products within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-1.27% 75.86M -11.74% 6.49B +24.75% 3.7B -3.48% 3.11B +2.36% 1.44B -15.13% 1.37B -25.63% 1.24B -7.91% 1.19B -10.84% 1.17B -.--% 1.05B
Veterinary Drugs
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1